Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
- None.
- None.
Live and Archived Fireside Chat Available at VirtualInvestorConferences.com
Date: March 7, 2024
Time: 11:00 a.m. Eastern time
Link: https://bit.ly/3OM3m93
Available for 1x1 meetings: March 7, 2024
This will be a live, interactive event where investors are invited to ask the company questions in real-time. An archived webcast will also be available after the event.
Investors are invited to pre-register and run a system check to expedite participation and receive event updates. For more information, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
About Kiromic BioPharma
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) 2.0 target discovery engine to develop and commercialize cell therapies focusing on immuno-oncology. Kiromic is developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma Delta T-cells to target solid tumors. Kiromic’s DIAMOND® AI is where data science meets target identification to dramatically compress the years and hundreds of millions of dollars required to develop a live drug. The Company maintains offices in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228415761/en/
Kiromic BioPharma
Linda Phelan Dyson, MPH
Global Head, Corporate Communications
ldyson@kiromic.com
281-468-7683
LHA Investor Relations
Tirth T. Patel
tpatel@lhai.com
212-201-6614
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
Source: Kiromic BioPharma, Inc.
FAQ
When will Kiromic BioPharma participate in the OTC Markets’ Life Science Investor Forum in a Fireside Chat format?
Who will be featured in the Fireside Chat event hosted by VirtualInvestorConferences.com?
What time will the event take place on March 7, 2024?
Will the event be interactive?
Is there an opportunity for investors to have 1x1 meetings with Kiromic BioPharma?